Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease

doi:10.3748/wjg.v12.i27.4369

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 27

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3259)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

357

HTML

2639

Figures (1-2)

137

Tables (1-4)

126

Sum=3259

Jul 21, 2006 (publication date) through Apr 27, 2024

Times Cited of This Article

Times Cited (39)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Jul 21, 2006; 12(27): 4369-4376
Published online Jul 21, 2006. doi: 10.3748/wjg.v12.i27.4369

Open in New Tab Full Size Figure Download Figure

Figure 1 Effect of different pharmacological interventions on liver mass/body mass ratio.

Open in New Tab Full Size Figure Download Figure

Figure 2 Effect of 6-wk rosiglitazone, metformin, ezetimibe, valsartan, or the combination of all the above drugs on percentage (%) of liver fat content in rats fed with MCD diet.

Citation: Assy N, Grozovski M, Bersudsky I, Szvalb S, Hussein O. Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease. World J Gastroenterol 2006; 12(27): 4369-4376
URL: https://www.wjgnet.com/1007-9327/full/v12/i27/4369.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i27.4369